APA (7th ed.) Citation

Denlinger, N., Bradbury, H., Doseck, N., Williams, J., Brown, D., Skinner, R., . . . Daneault, B. (2023). 825 - Process Development and Manufacturing: ONE YEAR FROM VECTOR TO BEDSIDE: RAMPING UP A SUCCESSFUL IN-HOUSE CAR T-CELL MANUFACTURING PROGRAM USING A NOVEL TRI-SPECIFIC CAR T-CELL THERAPY FOR LYMPHOID MALIGNANCIES. Cytotherapy (Elsevier Inc.), 25(6), S178. https://doi.org/10.1016/S1465-3249(23)00472-3

Chicago Style (17th ed.) Citation

Denlinger, N., et al. "825 - Process Development and Manufacturing: ONE YEAR FROM VECTOR TO BEDSIDE: RAMPING UP A SUCCESSFUL IN-HOUSE CAR T-CELL MANUFACTURING PROGRAM USING A NOVEL TRI-SPECIFIC CAR T-CELL THERAPY FOR LYMPHOID MALIGNANCIES." Cytotherapy (Elsevier Inc.) 25, no. 6 (2023): S178. https://doi.org/10.1016/S1465-3249(23)00472-3.

MLA (9th ed.) Citation

Denlinger, N., et al. "825 - Process Development and Manufacturing: ONE YEAR FROM VECTOR TO BEDSIDE: RAMPING UP A SUCCESSFUL IN-HOUSE CAR T-CELL MANUFACTURING PROGRAM USING A NOVEL TRI-SPECIFIC CAR T-CELL THERAPY FOR LYMPHOID MALIGNANCIES." Cytotherapy (Elsevier Inc.), vol. 25, no. 6, 2023, p. S178, https://doi.org/10.1016/S1465-3249(23)00472-3.